These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Molecular modeling of the dopamine D2 and serotonin 5-HT1A receptor binding modes of the enantiomers of 5-OMe-BPAT. Homan EJ; Wikström HV; Grol CJ Bioorg Med Chem; 1999 Sep; 7(9):1805-20. PubMed ID: 10530928 [TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics of dopamine at the D2 receptor. Dahl SG; Edvardsen O; Sylte I Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8111-5. PubMed ID: 1910173 [TBL] [Abstract][Full Text] [Related]
4. Homology modeling of the dopamine D2 receptor and its testing by docking of agonists and tricyclic antagonists. Teeter MM; Froimowitz M; Stec B; DuRand CJ J Med Chem; 1994 Sep; 37(18):2874-88. PubMed ID: 7915325 [TBL] [Abstract][Full Text] [Related]
5. Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. Trumpp-Kallmeyer S; Hoflack J; Bruinvels A; Hibert M J Med Chem; 1992 Sep; 35(19):3448-62. PubMed ID: 1328638 [TBL] [Abstract][Full Text] [Related]
6. Three dimensional models of the rat D2, D3 and D4 dopamine receptors. Livingstone CD; Strange PG; Naylor LH Biochem Soc Trans; 1992 May; 20(2):148S. PubMed ID: 1397542 [No Abstract] [Full Text] [Related]
7. High affinity agonist binding to the dopamine D3 receptor: chimeric receptors delineate a role for intracellular domains. Robinson SW; Jarvie KR; Caron MG Mol Pharmacol; 1994 Aug; 46(2):352-6. PubMed ID: 7915820 [TBL] [Abstract][Full Text] [Related]
8. Molecular modeling of interactions between tetrahydroprotoberberines and dopamine receptors. Tang Y; Chen KX; Jiang HL; Jin GZ; Ji RY Zhongguo Yao Li Xue Bao; 1996 Jan; 17(1):8-12. PubMed ID: 8737443 [TBL] [Abstract][Full Text] [Related]
9. Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors. Malmberg A; Nordvall G; Johansson AM; Mohell N; Hacksell U Mol Pharmacol; 1994 Aug; 46(2):299-312. PubMed ID: 8078492 [TBL] [Abstract][Full Text] [Related]
10. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors. Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114 [TBL] [Abstract][Full Text] [Related]
11. Mapping of dopamine D3 receptor binding site by pharmacological characterization of mutants expressed in CHO cells with the Semliki Forest virus system. Lundstrom K; Turpin MP; Large C; Robertson G; Thomas P; Lewell XQ J Recept Signal Transduct Res; 1998; 18(2-3):133-50. PubMed ID: 9651882 [TBL] [Abstract][Full Text] [Related]
12. On the use of the transmembrane domain of bacteriorhodopsin as a template for modeling the three-dimensional structure of guanine nucleotide-binding regulatory protein-coupled receptors. Pardo L; Ballesteros JA; Osman R; Weinstein H Proc Natl Acad Sci U S A; 1992 May; 89(9):4009-12. PubMed ID: 1315046 [TBL] [Abstract][Full Text] [Related]
13. Modeling the similarity and divergence of dopamine D2-like receptors and identification of validated ligand-receptor complexes. Boeckler F; Lanig H; Gmeiner P J Med Chem; 2005 Feb; 48(3):694-709. PubMed ID: 15689154 [TBL] [Abstract][Full Text] [Related]
14. Molecular evolution of adrenoceptors and dopamine receptors: implications for the binding of catecholamines. Xhaard H; Rantanen VV; Nyrönen T; Johnson MS J Med Chem; 2006 Mar; 49(5):1706-19. PubMed ID: 16509586 [TBL] [Abstract][Full Text] [Related]
15. A Complete Assessment of Dopamine Receptor- Ligand Interactions through Computational Methods. Bueschbell B; Barreto CAV; Preto AJ; Schiedel AC; Moreira IS Molecules; 2019 Mar; 24(7):. PubMed ID: 30934701 [No Abstract] [Full Text] [Related]
16. Transmembrane segment five serines of the D4 dopamine receptor uniquely influence the interactions of dopamine, norepinephrine, and Ro10-4548. Cummings DF; Ericksen SS; Goetz A; Schetz JA J Pharmacol Exp Ther; 2010 Jun; 333(3):682-95. PubMed ID: 20215412 [TBL] [Abstract][Full Text] [Related]
17. Dopamine receptor microdomains involved in molecular recognition and the regulation of drug affinity and function. Floresca CZ; Schetz JA J Recept Signal Transduct Res; 2004 Aug; 24(3):207-39. PubMed ID: 15521362 [TBL] [Abstract][Full Text] [Related]
18. Predicting subtype selectivity of dopamine receptor ligands with three-dimensional biologically relevant spectrum. Kuang ZK; Feng SY; Hu B; Wang D; He SB; Kong DX Chem Biol Drug Des; 2016 Dec; 88(6):859-872. PubMed ID: 27390270 [TBL] [Abstract][Full Text] [Related]
19. Molecular modeling of antipsychotic drugs and G protein coupled receptors. Dahl SG; Edvardsen O; Sylte I Therapie; 1991; 46(6):453-9. PubMed ID: 1819151 [TBL] [Abstract][Full Text] [Related]
20. Conformational analysis and receptor modelling of m1 and m2 selective antagonists. Kerckhoff H; Höltje HD Pharmazie; 1994 Aug; 49(8):566-73. PubMed ID: 7938144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]